Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Chronic Heart Failure

  Free Subscription


01.04.2024

2 Am J Cardiol
1 Ann Thorac Surg
1 Cardiovasc Res
1 Circ Cardiovasc Qual Outcomes
2 Circulation
1 Clin Cardiol
1 Coron Artery Dis
2 Eur Heart J
18 Eur J Heart Fail
2 Int J Cardiol
3 J Am Coll Cardiol
2 J Card Fail
1 J Cardiovasc Pharmacol
1 PLoS One


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Cardiol

  1. MEKARY W, Merchant FM
    Multipoint Pacing for Cardiac Resynchronization: Is the MPP Juice Worth the Battery Squeeze?
    Am J Cardiol. 2024;216:98-99.
    PubMed        

  2. AGARWAL S, Qamar U, Fujiwara Y, Guha A, et al
    The Effect of Sodium-Glucose Cotransporter 2 Inhibitors on Cardiovascular Outcomes in Patients with Cancer: A Systematic Review and Meta-Analysis.
    Am J Cardiol. 2024 Feb 17:S0002-9149(24)00101.
    PubMed        


    Ann Thorac Surg

  3. PENG DM, Davies RR, Simpson KE, Shugh SB, et al
    Seventh Annual Society of Thoracic Surgeons Pedimacs Report.
    Ann Thorac Surg. 2024;117:690-703.
    PubMed         Abstract available


    Cardiovasc Res

  4. RANGREZ AY, Frey N
    Reverse cardio-oncology: is heart failure-mediated gut dysbiosis the mechanistic driver of colorectal cancer progression?
    Cardiovasc Res. 2024 Mar 28:cvae051. doi: 10.1093.
    PubMed        


    Circ Cardiovasc Qual Outcomes

  5. OHASHI K, Matsue Y, Maeda D, Fujimoto Y, et al
    Impact of Multidomain Frailty on the Mode of Death in Older Patients With Heart Failure: A Cohort Study.
    Circ Cardiovasc Qual Outcomes. 2024 Mar 26:e010416.
    PubMed         Abstract available


    Circulation

  6. BERG-HANSEN K, Gopalasingam N, Christensen KH, Ladefoged B, et al
    Cardiovascular Effects of Oral Ketone Ester Treatment in Patients With Heart Failure With Reduced Ejection Fraction: A Randomized, Controlled, Double-Blind Trial.
    Circulation. 2024 Mar 27. doi: 10.1161/CIRCULATIONAHA.123.067971.
    PubMed         Abstract available

  7. GREEN JB, Everett BM, Ghosh A, Younes N, et al
    Cardiovascular Outcomes in GRADE (Glycemia Reduction Approaches in Type 2 Diabetes: A Comparative Effectiveness Study).
    Circulation. 2024 Feb 12. doi: 10.1161/CIRCULATIONAHA.123.066604.
    PubMed         Abstract available


    Clin Cardiol

  8. NABI R, Zahid T, Farooqi HA
    Utilizing machine learning for predicting heart failure outcomes: A path toward developing a patient-centered approach.
    Clin Cardiol. 2024;47:e24260.
    PubMed        


    Coron Artery Dis

  9. WANG F, Li C, Zhang X
    Sacubitril/valsartan improves the prognosis of acute myocardial infarction: a meta-analysis.
    Coron Artery Dis. 2024;35:231-238.
    PubMed         Abstract available


    Eur Heart J

  10. PEDICINO D, Volpe M
    Weekly journal scan: a hard RAFTing to improve long-term survival in heart failure with severely reduced ejection fraction.
    Eur Heart J. 2024 Mar 28:ehae167. doi: 10.1093.
    PubMed        

  11. HENRY CM, Oseran AS, Zheng Z, Dong H, et al
    Cardiovascular Hospitalizations and Mortality Among Adults Aged 25 to 64 years in the United States.
    Eur Heart J. 2023 Nov 11:ehad772. doi: 10.1093.
    PubMed         Abstract available


    Eur J Heart Fail

  12. SUBRAMANIAN V, Keshvani N, Segar MW, Kondamudi NJ, et al
    Association of global longitudinal strain by feature tracking cardiac magnetic resonance imaging with adverse outcomes among community-dwelling adults without cardiovascular disease: The Dallas Heart Study.
    Eur J Heart Fail. 2024;26:208-215.
    PubMed         Abstract available

  13. GARCIA-PAVIA P, Grogan M, Kale P, Berk JL, et al
    Impact of vutrisiran on exploratory cardiac parameters in hereditary transthyretin-mediated amyloidosis with polyneuropathy.
    Eur J Heart Fail. 2024;26:397-410.
    PubMed         Abstract available

  14. KRESOJA KP
    Exercise haemodynamics in post-Fontan patients: Diastolic dysfunction, again and again?
    Eur J Heart Fail. 2024;26:324-326.
    PubMed        

  15. MAEDER MT
    Natriuretic peptides - Biomarker companions through thick and thin.
    Eur J Heart Fail. 2024;26:270-273.
    PubMed        

  16. MONDA E, Limongelli G
    Expanding the knowledge on transthyretin p.V142I variant-related cardiomyopathy.
    Eur J Heart Fail. 2024;26:394-396.
    PubMed        

  17. SCISCIOLA L, Paolisso P, Belmonte M, Gallinoro E, et al
    Myocardial sodium-glucose cotransporter 2 expression and cardiac remodelling in patients with severe aortic stenosis: The BIO-AS study.
    Eur J Heart Fail. 2024;26:471-482.
    PubMed         Abstract available

  18. COUGHLAN JJ, Rossello X
    Anaemia in patients with cardiogenic shock complicating acute myocardial infarction: Surrogate marker of poor outcome or therapeutic target?
    Eur J Heart Fail. 2024;26:458-459.
    PubMed        

  19. MERKELY B, Kosztin A
    De novo versus upgrade cardiac resynchronization therapy: A different patient population and outcome?
    Eur J Heart Fail. 2024;26:521-522.
    PubMed        

  20. MEEKERS E, Petit T, Dauw J, Gruwez H, et al
    Analysing the accuracy of pressure measurements during exercise with pulmonary artery pressure sensors - Insights from the ACTION-MEMS study.
    Eur J Heart Fail. 2024;26:523-524.
    PubMed        

  21. MIRANDA WR, Jain CC, Borlaug BA, Connolly HM, et al
    Exercise catheterization in adults post-Fontan with normal and abnormal haemodynamic criteria: Insights into normal Fontan physiology.
    Eur J Heart Fail. 2024;26:314-323.
    PubMed         Abstract available

  22. OBRADOVIC D, Loncar G, Zeymer U, Poss J, et al
    Impact of anaemia and iron deficiency on outcomes in cardiogenic shock complicating acute myocardial infarction.
    Eur J Heart Fail. 2024;26:448-457.
    PubMed         Abstract available

  23. RAZVI Y, Ioannou A, Patel RK, Chacko L, et al
    Deep phenotyping of p.(V142I)-associated variant transthyretin amyloid cardiomyopathy: Distinct from wild-type transthyretin amyloidosis?
    Eur J Heart Fail. 2024;26:383-393.
    PubMed         Abstract available

  24. TRENSON S, Voros G, Martens P, Ingelaere S, et al
    Long-term outcome after upgrade to cardiac resynchronization therapy: A propensity score-matched analysis.
    Eur J Heart Fail. 2024;26:511-520.
    PubMed         Abstract available

  25. RICCARDI M, Pagnesi M, Chioncel O, Mebazaa A, et al
    Medical therapy of cardiogenic shock: Contemporary use of inotropes and vasopressors.
    Eur J Heart Fail. 2024;26:411-431.
    PubMed         Abstract available

  26. VAN DER LINDEN L, Karapinar-Carkit F, Forsyth P
    The pharmacist ally in heart failure: Useful when involved. Letter regarding the article 'Effective medications can work only in patients who take them: Implications for post-acute heart failure care'.
    Eur J Heart Fail. 2024 Mar 25. doi: 10.1002/ejhf.3217.
    PubMed        

  27. DEHARO F, Grapsa J
    Global longitudinal strain as a predictor of risk in patients with heart failure with preserved ejection fraction: A deserved role?
    Eur J Heart Fail. 2024 Mar 25. doi: 10.1002/ejhf.3211.
    PubMed        

  28. LIM J, Hashemian M, Blechter B, Roger VL, et al
    Pre-diagnostic free androgen and estradiol levels influence heart failure risk in both women and men: A prospective cohort study in the UK Biobank.
    Eur J Heart Fail. 2024 Mar 25. doi: 10.1002/ejhf.3189.
    PubMed         Abstract available

  29. DONAL E, Gegout L, Lee KC
    More than just a clinical syndrome: Biomarkers and echocardiography should be rapidly advised for anyone with suspected heart failure!
    Eur J Heart Fail. 2024 Mar 27. doi: 10.1002/ejhf.3201.
    PubMed        


    Int J Cardiol

  30. YAO L, Gong X, Liu Y, Hao K, et al
    The miR-195-3p/BDNF axis is a promising therapeutic for heart failure.
    Int J Cardiol. 2024 Mar 22:131991. doi: 10.1016/j.ijcard.2024.131991.
    PubMed        

  31. CHENG Y, Zhang Q
    Comment on "Subclinical myocardial injury increases the risk of heart failure in patients with and without type 2 diabetes post-acute coronary syndrome".
    Int J Cardiol. 2024 Mar 26:131979. doi: 10.1016/j.ijcard.2024.131979.
    PubMed        


    J Am Coll Cardiol

  32. HAGE C, Sundstrom J, Lund LH
    More evidence that heart failure with normal EF distinct from heart failure is below normal EF.
    J Am Coll Cardiol. 2024 Mar 12:S0735-1097(24)00990.
    PubMed        

  33. FOA A, Vaduganathan M, Claggett BL, Pabon MA, et al
    Sacubitril/Valsartan-Related Hypotension in Patients with Heart Failure and Preserved or Mildly Reduced Ejection Fraction.
    J Am Coll Cardiol. 2024 Mar 13:S0735-1097(24)00478.
    PubMed         Abstract available

  34. COTTER G, Davison B, Chioncel O
    Enhanced Decongestive Therapy in Patients With Acute Heart Failure: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2024;83:1243-1252.
    PubMed         Abstract available


    J Card Fail

  35. RICCARDI M, Cikes M, Adamo M, Pagnesi M, et al
    Functional mitral regurgitation and heart failure with preserved ejection fraction: clinical implications and management.
    J Card Fail. 2024 Mar 22:S1071-9164(24)00090.
    PubMed         Abstract available

  36. DE AVILA DX, di Candia AM, Moreira GR, Scaramussa VD, et al
    Growth differentiation factor-15 (GDF-15) and clinical outcomes in patients with chronic heart failure.
    J Card Fail. 2024 Mar 26:S1071-9164(24)00106.
    PubMed        


    J Cardiovasc Pharmacol

  37. ZHANG X, Wang Z, Zhang L, Zhao X, et al
    Comparative effectiveness and safety of intermittent, repeated or continuous use of levosimendan, milrinone, or dobutamine in patients with advanced heart failure: a network and single-arm meta-analysis.
    J Cardiovasc Pharmacol. 2024 Mar 25. doi: 10.1097/FJC.0000000000001561.
    PubMed         Abstract available


    PLoS One

  38. CHENG T, Yu D, Qiu X, OuYang W, et al
    The relationship between a series of inflammatory markers on the risk of heart failure in different gender groups: Analysis from NHANES 2015-2018.
    PLoS One. 2024;19:e0296936.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.